Deakin University
Browse

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

Version 2 2024-06-13, 15:00
Version 1 2021-11-29, 10:10
journal contribution
posted on 2024-06-13, 15:00 authored by N Horvath, A Spencer, M Kenealy, D Joshua, PJ Campbell, JJ Lee, J Hou, L Qiu, A Kalff, T Khong, A Londhe, S Siggins, M van Kooten Losio, M Eisbacher, HM Prince
Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

History

Journal

Leukemia & Lymphoma

Volume

60

Pagination

2122-2133

Location

Abingdon, Eng.

ISSN

1042-8194

eISSN

1029-2403

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

9

Publisher

Taylor & Francis

Usage metrics

    Research Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC